Switch to:
More From Other Websites
BMY Is Expected to See a Small Rise in Its 2017 Net Profit Margin Feb 27 2017
Exelixis Rockets On Bristol, Roche I-O Ties Following Merck-Incyte Team Feb 27 2017
Bristol-Myers Squibb Expects Modest Revenue Growth in 2017 Feb 27 2017
Cramer: Money's Being Thrown at Almost Everything in the Market Feb 27 2017
Analysts’ Recommendations for Bristol-Myers Squibb in 2017 Feb 27 2017
Why You Shouldn't Look Down On Your Depressed Colleagues Feb 27 2017
Billionaire Julian Robertson Bets Big on Technology Sector With These Stocks Feb 27 2017
[$$] VC Profile: OrbiMed Funds Novel Attacks on Cancer Feb 27 2017
Bristol-Myers Squibb to Take Part in Cowen and Company 37th Annual Global Health Care Conference Feb 27 2017
BRISTOL MYERS SQUIBB CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits Feb 27 2017
Bristol-Myers Squibb Expands International Immuno-Oncology Network (II-ON) With Addition of Columbia... Feb 27 2017
Exelixis and Bristol-Myers Squibb Enter Clinical Collaboration for Late-Stage Combination Trial in... Feb 27 2017
Bristol-Myers (BMY) Up 20.5% Since Earnings Report: Can It Continue? Feb 27 2017
IBM, Apple, Amazon: Doug Kass' Views Feb 27 2017
Cramer: I'll Give You the Key to the Rally Feb 24 2017
BRISTOL MYERS SQUIBB CO Financials Feb 24 2017
Pharma Stock Roundup: Is BMY the Next Acquisition Target? Priority Review for PFE, Novartis Drugs Feb 24 2017
Final Trade: ORCL, AN & more Feb 23 2017
Merck, Roche Gouge Bristol's I-O Share After Lung Cancer Approvals Feb 23 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK